Heart valve changes in atrial fibrillation patients
Part of Heart & circulation clinical trials.
This study looks at how atrial fibrillation (a common heart rhythm problem) affects the tricuspid valve—one of your heart's four valves. Researchers will use special ultrasound imaging to understand these changes and help improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (either occasional episodes or ongoing) or a normal heart with no history of atrial fibrillation
- You're scheduled for an ultrasound of your heart (echocardiogram) before or around the time of a heart rhythm procedure
- Your heart rate is stable during the ultrasound (averaging 110 beats per minute or less)
- You have not had prior ablation procedures for atrial fibrillation
- Your ultrasound images are clear enough for analysis
- You don't have moderate-to-severe leaking of the tricuspid valve, or moderate leaking of left-side heart valves
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating atrial fibrillation (an irregular heartbeat) early helps patients who also have tricuspid regurgitation (leakage in a heart valve). Researchers want to see if controlling the heart rhythm early can improve outcomes for people with both conditions.
This study is for people with atrial fibrillation who are planning to have a catheter ablation procedure. It will look at how well the heart works after the procedure and how to prevent future events.
This trial uses a special catheter to measure blood flow in patients with severe tricuspid regurgitation who are already scheduled for a valve repair or replacement. The goal is to see if this measurement helps doctors better predict who will benefit from the procedure.
This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study uses a special 3D heart ultrasound to measure how well the tricuspid valve and right side of the heart are working. It may help improve how these conditions are evaluated and followed over time.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.